Waldencast plc (WALD) 股票分析

公司概述

Waldencast plc operates within the beauty and wellness industry, specifically serving consumers in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand through its two primary segments: Obagi Medical and Milk Makeup. The company focuses on manufacturing and distributing skin care products designed to minimize signs of skin aging and address dark spots, positioning itself within the Consumer Defensive sector and the Household & Personal Products industry. This classification suggests that the company's products are often viewed as essential or discretionary purchases that provide tangible benefits to consumer health and appearance, potentially offering some resilience during economic downturns compared to luxury goods. With a market capitalization of $141.09M, an annual revenue of $272.07M, and an employee count of 367, Waldencast presents as a mid-sized enterprise in the competitive beauty landscape. These valuation figures indicate that the company operates with a relatively modest capital base compared to large-cap beauty giants, which may influence its ability to weather market fluctuations or invest heavily in research and development without significant dilution of ownership.

财务健康

Waldencast plc reported a trailing twelve-month revenue of $272.07M, yet it recorded a net income loss of $229,748,992, creating a substantial divergence that reveals a highly aggressive cost structure or significant one-time charges impacting the bottom line. The company generated an EBITDA of $-5,782,000, indicating that even before interest, taxes, depreciation, and amortization, the core operations faced a negative cash generation environment in the most recent period. Despite the negative net income, the company generated positive free cash flow of $115.17M, which provides a critical measure of financial flexibility by highlighting the ability to fund operations and capital expenditures without relying on external financing. This discrepancy between negative accounting net income and positive free cash flow often points to non-cash expenses like stock-based compensation or amortization that reduce reported earnings but do not immediately impact liquidity. The balance sheet shows a cash position of $30.38M against total debt of $149.01M, resulting in a debt-to-equity ratio of 29.80, which suggests a leveraged balance sheet where debt obligations exceed available cash reserves. Although the current ratio stands at 1.70, indicating that the company possesses $1.70 in current assets for every $1.00 of current liabilities and thus maintains reasonable short-term liquidity, the underlying leverage remains a key risk factor. Furthermore, the return on equity is -40.3% and the return on assets is -4.7%, metrics that reveal that management effectiveness is currently challenged by losses that erode shareholder value and utilize assets inefficiently in generating profit.

估值评估

The valuation metrics for Waldencast plc reflect its unprofitable status, with a trailing P/E ratio of N/A and a forward P/E of -2.16, implying that the market expects earnings to improve significantly or that traditional earnings-based valuation models are not yet applicable. The price-to-book ratio is 0.28, which indicates that the stock trades at a significant discount to its book value, suggesting the market prices the company well below the net asset value of its equity. Alternative valuation multiples such as the price-to-sales ratio of 0.52 and an EV/EBITDA of -49.62 provide context that investors are valuing the company primarily on its sales volume and revenue potential rather than current profitability. The 52-week high is $3.22 and the 52-week low is $0.86, and without the specific current price provided in the facts, the exact trading position relative to this range cannot be calculated, though the wide range suggests high volatility. The beta value is -0.07, a unique and counter-intuitive metric that suggests the stock's price movements are negatively correlated with or completely decoupled from the broader market, presenting an unusual risk profile for a typical equity investment.

Growth & Income

Waldencast plc experienced a revenue growth rate of -1.7% year-over-year, while earnings growth is listed as N/A due to the company's recent losses, implying that the business is currently contracting in terms of top-line sales rather than expanding. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means that instead of distributing cash to shareholders, the company retains all earnings to potentially fund operations, reduce debt, or invest in future growth initiatives. The absence of a dividend yield combined with negative profit margins indicates that the company reinvests its limited resources into maintaining market share or developing new product lines rather than returning capital to investors. Overall, the growth and income profile of Waldencast plc is characterized by revenue contraction and a lack of dividend income, relying entirely on operational improvements to eventually generate sustainable profits and positive cash flow in the future.